Table 4.
Analyzed pathways of proteomics data regulated in lung tissues of Bufei-Jianpi-formula-treated rats
| Term | Count | % | P-value |
|---|---|---|---|
| Focal adhesion | 16 | 9.0395 | 5.73E-07 |
| Tight junction | 13 | 7.3446 | 1.26E-06 |
| Adherens junction | 9 | 5.0847 | 2.66E-05 |
| Regulation of actin cytoskeleton | 14 | 7.9096 | 3.54E-05 |
| Leukocyte transendothelial migration | 10 | 5.6497 | 1.09E-04 |
| HCM | 8 | 4.5198 | 4.49E-04 |
| Dilated cardiomyopathy | 8 | 4.5198 | 6.83E-04 |
| ECM–receptor interaction | 7 | 3.9548 | 0.002147 |
| Prion diseases | 5 | 2.8249 | 0.002534 |
| Glycolysis/gluconeogenesis | 7 | 3.9548 | 0.002584 |
| ARVC | 6 | 3.3898 | 0.007467 |
| Antigen processing and presentation | 6 | 3.3898 | 0.01515 |
| Cardiac muscle contraction | 5 | 2.8249 | 0.040267 |
| Valine, leucine, and isoleucine degradation | 4 | 2.2599 | 0.040457 |
Abbreviations: ARVC, arrhythmogenic right ventricular cardiomyopathy; ECM, extracellular matrix; HCM, hypertrophic cardiomyopathy.